Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pancrelipase delayed release - Nestle

Next Previous
X
Search
Drug Profile

Pancrelipase delayed release - Nestle

Alternative Names: APT-1008; Enzepi; EUR-1008; EUR-1008M; Zenpep; Zentase

Latest Information Update: 02 Oct 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Eurand
  • Developer Allergan; Nestle
  • Class Pancreatic enzymes
  • Mechanism of Action Pancrelipase replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Pancreatic disorders

Most Recent Events

  • 05 May 2020 Allergan has divested the drugs Zenpep and Viokace to Nestle
  • 13 Mar 2018 Discontinued - Phase-III for Pancreatic disorders in Ukraine (PO) (NCT00788593)
  • 29 Apr 2016 The Committee for Medicinal Products for Human Use recommends approval of Pancrelipase for Pancreatic disorders (exocrine pancreatic insufficiency in patients with cystic fibrosis) in EU

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top